Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S D Gleason

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Behavioural Pharmacology|February 22, 2002
m-CPP hypolocomotion is selectively antagonized by compounds with high affinity for 5-HT(2C) receptors but not 5-HT(2A) or 5-HT(2B) receptorsS D Gleason, V L Lucaites, H E Shannon, et al.
The American Journal of Physiology|February 1, 1980
Lack of evidence for gastrointestinal control of sodium excretion in unanesthetized dogsR C Hanson, L A McLane-Vega, J W Childers, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 2012
In vivo occupancy of dopamine D3 receptors by antagonists produces neurochemical and behavioral effects of potential relevance to attention-deficit-hyperactivity disorderV Barth, A B Need, E T Tzavara, et al.
CNS & Neurological Disorders Drug Targets|April 12, 2013
mGlu2/3 agonist-induced hyperthermia: an in vivo assay for detection of mGlu2/3 receptor antagonism and its relation to antidepressant-like efficacy in miceS D Gleason, X Li, I A Smith, et al.
Pharmacology, Biochemistry, and Behavior|April 27, 2017
Further evaluation of the potential anxiolytic activity of imidazo[1,5-a][1,4]diazepin agents selective for α2/3-containing GABA<sub>A</sub> receptorsJ M Witkin, R Cerne, M Wakulchik, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 17, 2014
Perampanel, an antagonist of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors, for the treatment of epilepsy: studies in human epileptic brain and nonepileptic brain and in rodent modelsR Zwart, E Sher, X Ping, et al.
Pharmacology, Biochemistry, and Behavior|May 2, 2018
An antidepressant-related pharmacological signature for positive allosteric modulators of α2/3-containing GABA<sub>A</sub> receptorsK R Methuku, X Li, R Cerne, et al.
Neuropharmacology|May 21, 2018
Bioisosteres of ethyl 8-ethynyl-6-(pyridin-2-yl)-4H-benzo[f]imidazo [1,5-a][1,4]diazepine-3-carboxylate (HZ-166) as novel alpha 2,3 selective potentiators of GABA<sub>A</sub> receptors: Improved bioavailability enhances anticonvulsant efficacyJ M Witkin, J L Smith, X Ping, et al.
Pharmacology, Biochemistry, and Behavior|March 3, 2019
The α2,3-selective potentiator of GABA<sub>A</sub> receptors, KRM-II-81, reduces nociceptive-associated behaviors induced by formalin and spinal nerve ligation in ratsJ M Witkin, R Cerne, P G Davis, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Behavioural Pharmacology|February 22, 2002
m-CPP hypolocomotion is selectively antagonized by compounds with high affinity for 5-HT(2C) receptors but not 5-HT(2A) or 5-HT(2B) receptorsS D Gleason, V L Lucaites, H E Shannon, et al.
The American Journal of Physiology|February 1, 1980
Lack of evidence for gastrointestinal control of sodium excretion in unanesthetized dogsR C Hanson, L A McLane-Vega, J W Childers, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 2012
In vivo occupancy of dopamine D3 receptors by antagonists produces neurochemical and behavioral effects of potential relevance to attention-deficit-hyperactivity disorderV Barth, A B Need, E T Tzavara, et al.
CNS & Neurological Disorders Drug Targets|April 12, 2013
mGlu2/3 agonist-induced hyperthermia: an in vivo assay for detection of mGlu2/3 receptor antagonism and its relation to antidepressant-like efficacy in miceS D Gleason, X Li, I A Smith, et al.
Pharmacology, Biochemistry, and Behavior|April 27, 2017
Further evaluation of the potential anxiolytic activity of imidazo[1,5-a][1,4]diazepin agents selective for α2/3-containing GABA<sub>A</sub> receptorsJ M Witkin, R Cerne, M Wakulchik, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 17, 2014
Perampanel, an antagonist of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors, for the treatment of epilepsy: studies in human epileptic brain and nonepileptic brain and in rodent modelsR Zwart, E Sher, X Ping, et al.
Pharmacology, Biochemistry, and Behavior|May 2, 2018
An antidepressant-related pharmacological signature for positive allosteric modulators of α2/3-containing GABA<sub>A</sub> receptorsK R Methuku, X Li, R Cerne, et al.
Neuropharmacology|May 21, 2018
Bioisosteres of ethyl 8-ethynyl-6-(pyridin-2-yl)-4H-benzo[f]imidazo [1,5-a][1,4]diazepine-3-carboxylate (HZ-166) as novel alpha 2,3 selective potentiators of GABA<sub>A</sub> receptors: Improved bioavailability enhances anticonvulsant efficacyJ M Witkin, J L Smith, X Ping, et al.
Pharmacology, Biochemistry, and Behavior|March 3, 2019
The α2,3-selective potentiator of GABA<sub>A</sub> receptors, KRM-II-81, reduces nociceptive-associated behaviors induced by formalin and spinal nerve ligation in ratsJ M Witkin, R Cerne, P G Davis, et al.
Pageof 2